Product categoriesMedical Treatment

Products 31 to 40 of 44

Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: North America + Africa + Europe + Asia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 06:17 (5 years ago)
Known funding amount: 8,946 USD
Funding types: Crowdfunding
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Public Funding + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
rHuPH20 by Halozyme
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:37 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Input
SER150DN by Serodus + Evolva
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/09 16:29 (5 years ago)
Known funding amount: 102,000,000 NOK
Funding types: Private Funding
Industry: Health
Market status: Under Development + More information needed
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Sitagliptin by Codexis
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 37,000,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: CDXS (NASDAQ)
Value chain stage: Input
Biotech components: Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (3 years ago)
Date last modified: 2020/12/18 14:40 (3 years ago)
Known funding amount: 28,500,000 USD
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Vaxonella by Prokarium
Biotech components: Bacteria
Business models: B2C
Country of production: UK
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 16:12 (5 years ago)
Known funding amount: 12,600,000 USD
Funding types: Venture Capital
Industry: Health
Market status: On the market + Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
SYN-004 (RIBAXAMASE) by Synthetic Biologics
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 12,467,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
SYN-005 by Synthetic Biologics + Intrexon
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:27 (5 years ago)
Known funding amount: 24,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
SYNB1020 by Synlogic
Biotech components: Microbe
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer + Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 125,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYBX (NASDAQ)
Value chain stage: Finished Product